Tina leads the new-product-launch work in McKinsey’s Life Sciences Practice in China and has extensive experience in launch excellence issues. She has served leading biotechnology and pharmaceutical companies on commercial-excellence issues, such as new product launch, commercial model innovation, sales-force optimization, and marketing-capability building.
Tina has coauthored several white papers on China’s healthcare market including “In search of new business models for Big Pharma in China” and “Building bridges to innovation” for Biocentury’s China Healthcare Summit (2013–2016).
Published work
“Managing China’s growing oncology burden,” McKinsey & Company, August 2020
Education
Harvard University
MBA
Fudan University
BBA, management science